Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: A multi-site study performed at high volume cancer centers
Amanda N. Fader(Johns Hopkins University), Paola A. Gehrig(University of North Carolina at Chapel Hill), Kristine Zanotti(University Hospitals Cleveland Medical Center), Heidi E. Frasure(University Hospitals of Cleveland), Gregory Skafianos(Duke Medical Center), John F. Boggess(University of North Carolina at Chapel Hill), Jeffrey M. Fowler(Columbus Center), Angeles Alvarez Secord(Duke University), Pedro F. Escobar(San Juan Bautista School of Medicine), David E. Cohn(The Ohio State University), Emma Rossi(Indiana University – Purdue University Indianapolis), L. Havrilesky(Duke Medical Center), Leigh G. Seamon(The Ohio State University)
Cited by 109
Related Papers
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
|The Lancet Oncology|2019|533
Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial
|The Lancet Oncology|2018|342
Laparoendoscopic single-site surgery (LESS) in gynecologic oncology: Technique and initial report
|Gynecologic Oncology|2009|314